Particle Counters - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The particle counters market size is estimated at USD 276.43 million in 2026, and is expected to reach USD 391.53 million by 2031, at a CAGR of 7.21% during the forecast period (2026-2031). This report is Segmented by Product Type (Airborne Particle Counters, and More), Application (Cleanroom Monitoring, and More), Modality (Benchtop, Portable, and Remote), End User (Pharmaceutical and Biotechnology Companies, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Particle Counters Market Trends and Insights

Stricter Global Cleanroom Standards (ISO 14644 & GMP Annex 1)

As of August 2023, Annex 1 requires sterile drug manufacturers to maintain continuous particle logs in Grade A and B zones, replacing periodic spot checks. ISO 14644-5:2025 further allows operators to extend requalification intervals from six to 24 months when online data demonstrates compliance, thereby reducing downtime and validation costs. Instruments such as Beckman Coulter’s MET ONE 3400+ automate SOPs and audit trails, ensuring one-click compliance for FDA inspectors[1]. Companies that have delayed upgrades now face heightened regulatory scrutiny, accelerating a replacement wave across legacy handheld fleets.

Rapid Growth in Biologics and Cell-Therapy Manufacturing

Single-use bioreactors pose unseen breach risks, prompting CDMOs to install real-time particle counters in filling suites that can flag bag failures before USD 5 million batches are lost. The FDA’s 2024 guidance on advanced therapies treats environmental monitoring as a critical quality attribute, cementing continuous particle trending as standard practice. TSI’s BioTrak counter differentiates viable microbes from inert particles, closing a long-standing data gap that once forced operators to cross-reference separate air samplers. More than 1,200 active cell-therapy trials concentrate demand in the United States and China, fuelling strong unit sales to facilities that reconfigure cleanrooms between campaigns.

High Capital Expenditure for HEPA-Grade Controlled Environments

Constructing an ISO Class 7 cleanroom averages USD 1,500-3,000 per ft², while a 20-counter network can add USD 200,000 in hardware alone. Recurring services - such as filters, calibration, and licenses - absorb 20-30% of that outlay each year, posing a challenge to smaller CDMOs and academic labs. Many generic producers in Southeast Asia, therefore, rely on handheld validation instead of continuous monitoring, accepting higher regulatory risk to conserve cash. Leasing and calibration-as-a-service models have emerged, yet uptake is slow because asset-heavy firms prefer ownership for depreciation benefits.

Other drivers and restraints analyzed in the detailed report include:

• Accelerating Semiconductor Node Shrink Demanding Sub-Micron Monitoring
• Surge in EV Battery Gigafactories and Ultra-Dry Room Adoption
• Scarcity of Certified Calibration Technicians and Laboratories

Segment Analysis

Airborne particle counters retained 61.42% of the particle counters market share in 2025, cementing their role in pharmaceutical cleanrooms, wafer fabs, and national monitoring grids. Liquid particle counters, however, will register a 9.32% CAGR through 2031 as fabs push UPW purity into the single-digit parts-per-trillion range and gigafactories police deionized rinse water for metallic seeds that trigger dendrites. The particle counters market size for liquid applications is thus poised to narrow the volume gap with airborne units, while commanding higher margins due to sub-10 nm detection requirements.

Vendors now integrate aerosolization stages and water-based condensation optics to bypass Mie-scattering limits, enabling actual resolutions of 10 nm. Instruments such as the Nano LPM carry a 20-30% price premium but justify the cost by preventing scrap on USD 5 billion lithography lines. In contrast, aerodynamic and condensation sizers are used in inhaler validation, atmospheric science, and diesel filter testing. Although collectively accounting for less than 10% of shipment volume, these niche devices sustain steady demand from academic labs and regulatory agencies that require ultrafine resolution beyond standard optical microscopes.

Cleanroom Monitoring generated 64.09% of 2025 revenue as Annex 1 and ISO 14644 automation turned real-time logging from best practice into baseline expectation[3]. Yet Aerosol Monitoring and Research will post the quickest growth at 8.97% CAGR to 2031, propelled by the NSF’s ASCENT network and DOE aerosols-cloud programs that flood universities with grant funds for SMPS and condensation counters. The particle counters market size for research is therefore expanding faster than legacy pharma demand, a signal that public health and climate science are shifting industry frontiers.

Projects exploring ultrafine links to Alzheimer’s, cardiovascular disease, and atmospheric radiative forcing require instruments down to 10 nm. Manufacturers respond with dual-mode units that toggle between airborne and liquid channels, letting investigators capture both particle size and chemical fingerprint in a single run. Pharmaceutical and semiconductor labs also leverage these research-grade features to map root-cause mechanisms behind micro-contamination, blurring historical lines between production QA and academic discovery.

Complete Report Scope:

• By Product Type
  • Airborne Particle Counters
  • Liquid Particle Counters
  • Other Product Types
• By Application
  • Cleanroom Monitoring
  • Contamination Monitoring of Liquids
  • Aerosol Monitoring and Research
• By Modality
  • Benchtop
  • Portable
  • Remote
• By End User
  • Pharmaceutical and Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Academic and Research Institutes
  • Other End Users
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 41.65% of 2025 revenue, supported by FDA Annex 1-equivalent oversight and CHIPS Act incentives that underwrite the construction of new fabs in Arizona and Ohio. The particle counters market size in the region expands steadily because pharma and logic-node leaders treat continuous monitoring as non-negotiable for compliance and yield. ISO/IEC 17025 coverage exceeds 50 accredited labs, trimming calibration downtime to under one week. Local incumbents leverage this service network to lock in annuity contracts and defend share against price-focused imports.

The Asia-Pacific region will record the fastest growth at an 8.18% CAGR through 2031, as India and China invest billions in ambient networks, and as Taiwan, Japan, and South Korea ramp up 2-nm production lines. Government allocations - Rs. 19,614 crore in India and CNY 30 billion in China - fortify public tenders that often bundle calibration services to overcome technician scarcity. Meanwhile, over 80 EV battery plants across China, Korea, and Japan embed hundreds of remote counters per site, rapidly expanding the installed base. Vendors offering turnkey calibration-as-a-service gain traction because only 30 accredited aerosol labs serve the entire sub-continent, making on-site verification far more practical.

Europe claims roughly 23% share but faces headwinds. Intel has postponed its EUR 30 billion Magdeburg fab, and ASML shipped only 60 EUV tools in 2025, down from earlier projections, which has muted fresh equipment orders. Growth instead rests on Annex 1 replacement cycles and on battery-cell lines such as Volkswagen’s Salzgitter and Northvolt’s Ett, which still trail Asia in capacity. The region benefits from a dense calibration infrastructure at PTB and NPL, ensuring compliance speed; however, suppliers are increasingly pivoting toward software upgrades and sensor retrofits to offset lulls in new installations.

The Middle East & Africa, as well as South America, jointly contribute under 10% but hold latent upside. Brazil’s adoption of Annex 1-style monitoring in 2024 forces local drug makers to modernize, yet the absence of domestic calibration labs slows rollouts. Gulf states exploring local semiconductor fabs could unlock demand for instruments, but projects remain at the feasibility stage. In both regions, portable counters validated against transfer standards offer a stopgap until home-grown metrology capacity matures.

List of Companies Covered in this Report:

• Beckman Coulter (Danaher)
• Chemtrac Systems
• Climet Instruments Company
• Danaher
• Fortive
• Hal Technology LLC
• Kanomax USA, Inc.
• Lighthouse Worldwide Solutions
• Markus Klotz
• Met One Instruments Inc.
• Microtrac Retsch GmbH
• PAMAS Partikelmess- Und Analysesysteme GmbH
• Particle Plus Inc.
• RION
• Spectris
• Suzhou Honri Airclean Technology Co., Ltd.
• Topas GmbH
• TSI Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support